<DOC>
	<DOC>NCT00885352</DOC>
	<brief_summary>This study will examine the safety and efficacy of the addition of sitagliptin (MK-0431) compared to placebo in patients with type 2 diabetes mellitus with inadequate glycemic control who are taking pioglitazone and metformin.</brief_summary>
	<brief_title>Sitagliptin (MK-0431) vs. Placebo in Patients With Inadequate Glycemic Control on Metformin With Pioglitazone (MK-0431-128)</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Pioglitazone</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Sitagliptin Phosphate</mesh_term>
	<mesh_term>Glipizide</mesh_term>
	<criteria>has type 2 diabetes and is at least 18 years of age and no older than 78 years of age is male or is a female who is unlikely to conceive children is on stable doses of a peroxisome proliferatoractivated receptor gamma agonist and metformin OR metformin and a sulfonylurea agent has type 1 diabetes has taken a dipeptidyl peptidase (DPP4) inhibitor or a glucagonlike peptide1 (GLP1) analogue is on a weight loss program that is not in the maintenance phase or has started a weight loss medication within 8 weeks of screening has had surgery within 30 days of screening or has major surgery planned during the study is on or is likely to require treatment with corticosteroids for more than 2 weeks has a history of active liver disease, including hepatitis B or C, cirrhosis, or gallbladder disease is human immunodeficiency virus (HIV) positive has congestive heart failure, or has had new or worsening symptoms of coronary heart disease within 3 months prior to screening has had acute coronary syndrome, coronary artery intervention, or stroke within 3 months of screening has severe active peripheral vascular disease has a history of cancer or blood disorder is pregnant or breast feeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>78 Years</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>